Wehave recently devised a new, simple and rapid method, (unpublished data), for screening a great number of microbial colonies for cytotoxic and antiviral activity, which has led to the detection of some microbial strains with interesting antiviral properties1*. Amongthese, was a strain of Pseudomonas fluorescens/putida SS-3, which produced the biologically active compound karalicin. The taxonomy of the producing strain, fermentation, isolation, physico-chemical properties and structure elucidation of karalicin have been reported in a separate paper2). In this paper we describe the biological properties of this compound, which has shown an inhibitory effect on the multiplication of herpes viruses in vitro. 
Materials and Methods

Cell and Viruses
263
The heteroploid cell line, Vero, and euploid embryonic 
Cytotoxicity Assays
For all the experiments, karalicin was dissolved in DMSO(BDH) at the concentration of lOmg/ml and it was diluted at least 100 fold in test mediumbefore use. The viral plaque reduction test was performed in 35 mmpetri dishes containing a con fluent cell monolayer. About 200 infectious viruses per plate were incubated for 1 hour at room temperature. Then the cells were covered with a purified agar solidified nutrient medium. After 2~3 days the plaques were stained with 0.01% neutral red and counted macroscopically. The ID50 was defined as the dose of the substance that inhibited either viral plaque formation or viral cytopathic effect by 50%.
Irreversibility of Antiviral Activity and the Action of
Karalicin on the Viral Cycle For the experiments on the reversibility of the antiviral activity of karalicin, Vero cells were infected with HSV1 at a MOIof 0.1. Karalicin was added at time 0 after infection in a concentration of 0.032/ig/ml. The compound was left in the culture for different times (from 0 to 10 hours) then it was removed and the cells, covered with fresh medium, were incubated for a further 24 hours.
The viruses produced, were titrated as plaque forming units on Vero cells.
To study the action of karalicin on the viral cycle, the drug (0.032/xg/ml) was added to HSV1 infected cells at different times after infection. Karalicin was added into the plates (in triplicate) from 0 to 10 hours after infection. After 24 hours of incubation in a CO2incubator at 37°C, the cells were collected and the virus was titrated as plaque forming units. MAR. 1996 Antibiotic Activity Assay For antibacterial and antifungal assays the following strains were used: Staphylococcus aureus ATCC25932, Enterococcus faecalis ATCC27989, Escherichia coli ATCC25922, Candida albicans CDCB385 and Y0109, C. kefyr Y0601, C. tropicalis CBS94. Pseudomonas aeruginosa Cal was from our Institute's collection and was identified according to conventional procedures3).
Antibacterial and antifungal activity was studied by a dilution method in multiwell plates with the use of Muller-Hinton broth (for bacteria)4) and Sabouraud broth (for fungi) according to standard conditions5).
Results
The toxicity of karalicin was studied on both Vero Under these experimental conditions, no effect was observed on thymidine uptake in both viral-infected or uninfected cells. Leucine uptake was slightly inhibited in both types of cells, but in infected cells it was reduced more than in uninfected ones. Only at 0.064fig/ml karalicin reduced leucine incorporation by about 50%.
Uridine uptake decreased in non-infected cells from 0.064jug/ml onwards, whilst it was even enhanced in HSV1 infected cells at drug concentrations from 0.016 to 0.045 jug/ml. A contact time of as low as 1 hour for karalicin with HSV1infected cells resulted in an inhibition of more than 50% of viral yield (Fig. 3a) . 8 hours of contact between the drug and the infected cells were sufficient to block viral replication by more than 99%. These findings suggest that the action ofkaralicin on viral multiplication is not reversed by removal of the drug from the culture.
It resulted, as shownin Fig. 3b , that the virus was still inhibited by karalicin by more than 90% even when the drug was added 10 hours after infection; at this time most steps of the viral cycle are almost completed and only virus morphogenesis is still ongoing. Table 3 shows the minimum inhibiting concentrations (MIC) of karalicin against various microorganisms. Only a modest antifungal effect was observed, in particular on Candida albicans with a MIC of 12 /ig/ml and on C. kefyr with a MIC of 0.75jUg/ml; no effect on bacteria was observed.
Discussion
Pseudomonasfluorescens has been found to produce several bioactive compounds. Amongthem pyoluteorin6), pyrrolnitrin7), 2,4-diacetylphloroglucinol8), hydrogen cyanide9) and pyoverdine siderophore9) were described.
In this paper a new biologically active substance, named karalicin, has been described as being produced by an environmental strain belonging to this species. in fact, a few hours of contact between karalicin and infected cells during viral multiplication blocked viral growth, even though the substance was removed from the culture medium. Furthermore, the addition of karalicin to the cells up to 10 hours after infection still resulted in more than 90% viral inhibition. Taken together, these findings suggest that karalicin specifically affects some step in viral multiplication, which is irreversibly impaired. RNAwas found to accumulate in virus-infected cells, but not in uninfected ones; this fact is not surprising, since other antibiotics which affect proteins synthesis, such as cycloheximide, gave similar results in our hands on HSV1(data not shown) and by other authors on different viruses10'11]. In addition, considering that DNA synthesis was unaffected by karalicin at non-toxic doses and that leucine uptake seemed the activity mainly affected by it, especially in HSV1infected cells, we suggest that some step in the protein synthesis regulation or in viral morphogenesis are the most likely to be altered.
